Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Viridian Therapeutics Ors Shs (VRDN)  
$14.33 0.22 (1.51%) as of 4:30 Fri 6/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 94,500,000
Market Cap: 1.35(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.02 - $25.71
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  797
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Viridian Therapeutics is a biotechnology company. Co. has built relevant capabilities in monoclonal antibody discovery and engineering, biologics manufacturing, and nonclinical and clinical development for thyroid eye disease (TED) and other undisclosed target indications. Co. is developing two product candidates, VRDN-001 and VRDN-002, to treat patients who suffer from TED. Co.'s key program, VRDN-001, is a humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) for the treatment for TED. VRDN-002, a distinct IGF-1R antibody is designed to support administration as a convenient, low volume, subcutaneous injection to treat patients who suffer from TED.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,626,400 2,102,590
Total Buy Value $0 $0 $30,616,312 $40,616,302
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 3 4
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 118
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Fairmount Healthcare Fund Ii L.p. Director   –       •       •   2025-06-10 4 OE $12.31 $153,875 I/I 12,500 3,459,913     -
   Fairmount Healthcare Fund Ii L.p. Director   –       •       •   2025-06-09 4 OE $7.80 $12,480 I/I 1,600 3,447,413     -
   Mahoney Stephen F. President and CEO   •       •      –    2024-09-27 4 B $23.33 $499,262 D/D 21,400 21,400 0.01 -24%     
   Beetham Thomas W. Chief Operating Officer   •       –      –    2024-09-27 4 B $23.41 $117,050 D/D 5,000 6,000 0.01 -24%     
   Fairmount Healthcare Fund Ii L.p. Director   –       •       •   2024-09-13 4 B $18.75 $30,000,000 I/I 1,600,000 3,445,813 2.25 -16%     
   Fairmount Healthcare Fund Ii L.p.   –       •       •   2024-03-28 4 A $0.00 $0 I/I 5,859 1,845,813     -
   Fairmount Healthcare Fund Ii L.p.   –       •       •   2024-03-28 4 D $0.00 $0 I/I (5,859) 0     -
   Fairmount Healthcare Fund Ii L.p. See Remarks   –       •       •   2024-01-22 4 B $21.00 $9,999,990 I/I 476,190 1,839,954 0.01 -40%     
   Ciulla Thomas Chief Medical Officer   •       –      –    2024-01-03 3 IO $0.00 $0 D/D 0 762 -32%     
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-06 4 AS $25.02 $128,253 D/D (5,126) 29,971 -51%     
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-06 4 OE $18.51 $94,882 D/D 5,126 35,097     -
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-05 4 AS $25.03 $12,490 D/D (499) 29,971 -51%     
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-05 4 OE $18.51 $9,236 D/D 499 30,470     -
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-02 4 AS $24.21 $45,394 D/D (1,875) 29,971 -45%     
   Meisner Lara Chief Legal Officer   •       –      –    2023-06-02 4 OE $14.00 $26,250 D/D 1,875 31,846     -
   Myers Scott Dunseth Chief Executive Officer   •       •      –    2023-04-12 4 B $25.37 $101,479 D/D 4,000 259,500 0.01 -21%     
   Myers Scott Dunseth Chief Executive Officer   •       •      –    2023-03-13 4 B $29.15 $160,324 D/D 5,500 255,500 0.01 -29%     
   Meisner Lara General Counsel and Secretary   •       –      –    2023-03-09 4 AS $29.07 $871,257 D/D (29,971) 0 -26%     
   Myers Scott Dunseth Chief Executive Officer   •       •      –    2023-02-06 4 A $0.00 $0 D/D 250,000 250,000     -
   Violin Jonathan Chief Executive Officer   •       •      –    2023-02-02 4/A AS $36.80 $1,840,000 D/D (50,000) 480,905     -
   Violin Jonathan Chief Executive Officer   •       •      –    2023-02-02 4/A OE $0.15 $7,500 D/D 50,000 530,905     -
   Violin Jonathan Chief Executive Officer   •       •      –    2023-02-02 4 AS $36.80 $1,840,000 D/D (50,000) 430,905 -28%     
   Meisner Lara General Counsel and Secretary   •       –      –    2023-01-23 4 AS $35.66 $244,021 D/D (6,843) 0 -31%     
   Meisner Lara General Counsel and Secretary   •       –      –    2023-01-23 4 OE $14.00 $140,690 D/D 6,843 6,843     -
   Katz Barrett Chief Medical Officer   •       –      –    2023-01-17 4 AS $37.21 $924,780 D/D (24,853) 0 -37%     

  118 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed